Dr Reddys Laboratories informs about press release

12 May 2021 Evaluate
Dr Reddys Laboratories has informed that it has enclosed a Press Release on ‘Dr. Reddy's Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to Covid-19 Treatment in India.’

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1267.15 -7.90 (-0.62%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×